Vireo Growth VREOF
OTC VREOF
$10.97 -0.01 (-0.09%)
At close: Aug 19, 2026 · 3:35 PM UTC

Vireo Growth (VREOF) Other Operating Expenses (2020 - 2026)

Vireo Growth (VREOF) posted Other Operating Expenses of $10.8 million for Q1 2026, down 20.28% sequentially from $13.5 million in Q4 2025, and up 730.77% YoY from $1.3 million in Q1 2025.

Vireo Growth (VREOF) Other Operating Expenses (2020 - 2026) Analysis & Trends

Vireo Growth has reported Other Operating Expenses for 7 years, with the latest figure at $10.8 million in Q1 2026.

  • Quarterly Other Operating Expenses rose 730.77% year-over-year to $10.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.1 million (up 443.1% YoY) and the FY2025 annual result came in at $21.9 million, up 900.14% from the prior year.
  • Other Operating Expenses retreated to $10.8 million in Q1 2026 per VREOF's latest filing, from $13.5 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $13.5 million in Q4 2025 and troughed at -$8.6 million in Q4 2022.
  • A 5-year average of $2.0 million and a median of $168359.0 in 2022 frame the typical range for Other Operating Expenses.
  • The sharpest annual moves came in 2023 and 2025: Other Operating Expenses plunged 10958.5% in 2023, then soared 49411.94% in 2025.
  • Over 5 years, Other Operating Expenses stood at -$8.6 million in 2022, then soared by 94.43% to -$478476.0 in 2023, then jumped by 1515.95% to $6.8 million in 2024, then soared by 99.95% to $13.5 million in 2025, then retreated by 20.28% to $10.8 million in 2026.
  • According to Business Quant data, Other Operating Expenses over the past three periods registered $10.8 million, $13.5 million, and $6.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.81 Bn 42.84 Bn -
2 Teva Pharmaceutical Industries 43.29 Bn 39.63 Bn 2.15 Bn
3 Zoetis 31.59 Bn 29.91 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.67 Bn 22.88 Bn 5.10 Bn
5 United Therapeutics 22.24 Bn 19.58 Bn 683.80 Mn
6 Viatris 18.79 Bn 17.91 Bn 1.46 Bn
7 Neurocrine Biosciences 15.71 Bn 15.32 Bn 935.80 Mn
8 Elanco Animal Health 12.09 Bn 11.56 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn -
10 Vireo Growth 492.80 Mn 350.50 Mn 95.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.80 Mn
Dec 31, 2025 13.55 Mn
Sep 30, 2025 6.09 Mn
Jun 30, 2025 6.65 Mn
Mar 31, 2025 1.30 Mn
Dec 31, 2024 6.77 Mn
Sep 30, 2024 -12,349.00
Jun 30, 2024 -1.23 Mn
Mar 31, 2024 -887,212.00
Dec 31, 2023 -478,476.00
Sep 30, 2023 -823,400.00
Jun 30, 2023 719,679.00
Mar 31, 2023 386,165.00
Dec 31, 2022 -8.59 Mn
Sep 30, 2022 7,583.00
Jun 30, 2022 -10,930.00
Mar 31, 2022 168,359.00
Dec 31, 2021 6.47 Mn
Mar 31, 2021 437,107.00
Dec 31, 2020 3.37 Mn